Pradhan Mantri Bhartiya Janaushadhi Kendras Revolutionizing Generic Medicine Access
The Indian government’s efforts to enhance access to affordable and quality healthcare have seen a significant boost with the establishment of 9,512 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) across the country. These centers, under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), aim to provide the common man with generic medicines at affordable prices. With a target to open 10,000 PMBJKs by March 2024, the initiative is making strides in improving healthcare accessibility for all.
Promoting Generic Medicines through Regulatory Measures
In addition to setting up PMBJKs, the government is taking regulatory measures to ensure the quality and availability of generic medicines. The Indian Medical Council mandates physicians to prescribe drugs using generic names, making it easier for patients to access affordable alternatives. Central Government hospitals, CGHS Doctors, and Wellness Centres are also directed to prescribe generic medicines exclusively, further encouraging the use of affordable healthcare solutions.
Raising Awareness through Public Initiatives
To promote the PMBJP scheme, the Department of Pharmaceuticals and Pharmaceuticals & Medical Devices Bureau of India (PMBI) collaborates with state/UT governments and district administrations to create awareness and facilitate the opening of Janaushadhi Kendras in various health facilities. Through extensive advertising campaigns across print media, radio, TV, cinema, and outdoor mediums, the public is continually educated about the benefits of Jan Aushadhi generic medicines. Celebrations like Jan Aushadhi Diwas and educational workshops further spread awareness about the scheme.
Update on Access to Generic Medicines
9,512 Pradhan Mantri Bhartiya Janaushadhi Kendras have been opened across the country
— PIB India (@PIB_India) July 21, 2023
Ensuring Drug Quality through Stringent Regulations
To maintain the efficacy and safety of medicines, the Drugs and Cosmetics Act has undergone amendments to impose severe penalties for manufacturing spurious and adulterated drugs. Special courts have been established for speedy trials, and the number of sanctioned posts in Central Drugs Standard Control Organization (CDSCO) has been increased. Stringent inspection and evidence submission requirements before granting manufacturing licenses further ensure the quality of drugs in the market.
The successful establishment of 9,512 Pradhan Mantri Bhartiya Janaushadhi Kendras across India marks a significant milestone in improving access to generic medicines for the general public. With targeted efforts to raise awareness about the benefits of affordable healthcare solutions and stringent regulatory measures to maintain drug quality, the government is actively working towards making quality healthcare accessible to all citizens.